These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7287590)

  • 1. In vitro synergism of FR-31564, a new phosphonic acid antibiotic.
    Yokota Y; Murakawa T; Nishida M
    J Antibiot (Tokyo); 1981 Jul; 34(7):876-83. PubMed ID: 7287590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic.
    Mine Y; Kamimura T; Nonoyama S; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1980 Jan; 33(1):36-43. PubMed ID: 7372548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
    Neu HC; Kamimura T
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1013-23. PubMed ID: 7271270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms.
    Sakamoto M; Ishikura T; Fukagawa Y
    J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.
    Neu HC; Kamimura T
    Antimicrob Agents Chemother; 1982 Oct; 22(4):560-3. PubMed ID: 7181471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of fosfomycin in vitro.
    Forsgren A; Walder M
    J Antimicrob Chemother; 1983 May; 11(5):467-71. PubMed ID: 6874631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial activities of monobactams against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the combination of erythromycin with new beta-lactam antibiotics against gram-negative aerobic respiratory pathogens.
    Nakatomi M; Neu HC
    Chemioterapia; 1986 Dec; 5(6):379-84. PubMed ID: 3802298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.
    Ito R; Tomich AD; McElheny CL; Mettus RT; Sluis-Cremer N; Doi Y
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():95-101. PubMed ID: 2786520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination effect of fosfomycin to beta-lactam, aminoglycoside, and macrolide antibiotics against clinical isolates of Klebsiella pneumoniae].
    O'Hara K; Nakamura A; Shigenobu F; Chen J; Sawai T
    Jpn J Antibiot; 1997 Aug; 50(8):704-10. PubMed ID: 9339396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined action of phosphomycin with streptomycin and gentamicin.
    Miksza-Zyłlkiewicz R; Dzierzanowska D; Linda H; Borowski J
    Arch Immunol Ther Exp (Warsz); 1977; 25(6):741-7. PubMed ID: 348150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of synergistic effects of beta-lactam antibiotic combinations on gram-negative bacilli.
    Farrar WE; Newsome JK
    Antimicrob Agents Chemother; 1973 Aug; 4(2):109-14. PubMed ID: 4598215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
    Chin NX; Neu NM; Neu HC
    Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial susceptibility of enterobacteriaceae isolated from raw horsemeat isolated for human consumption (basashi).
    Furuhata K; Ishizaki N; Fukuyama M
    Biocontrol Sci; 2015; 20(1):19-25. PubMed ID: 25817809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FR-31564, a new phosphonic acid antibiotic: bacterial resistance and membrane permeability.
    Kojo H; Shigi Y; Nishida M
    J Antibiot (Tokyo); 1980 Jan; 33(1):44-8. PubMed ID: 7378171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].
    Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
    Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.